| COPD | Chronic obstructive pulmonary disease. |
| NF-κB | Nuclear factor kappa B. |
| RelA | p65. |
| PRRs | Pattern recognition receptors. |
| PAMPs | Pathogen-associated molecular patterns. |
| DAMPs | Damage-associated molecular patterns. |
| TLRs | Toll-like receptors. |
| MyD88 | Myeloid differentiation primary response 88. |
| TRIF | TIR-domain containing adapter-inducing interferon-beta. |
| IKK | Inhibitor of NF-κB kinase. |
| IκBα | Inhibitor of NF-κB. |
| COX-2 | Cyclooxygenase-2. |
| iNOS | Inducible NO synthase. |
| IL | Interleukin. |
| TNF-α | Tumor necrosis factor-alpha. |
| NLPR3 | NLR family pyrin domain containing 3. |
| NSAIDs | Nonsteroidal anti-inflammatory drugs. |
| PPD | Protopanaxadiol. |
| PPT | Protopanaxatriol. |
| OA | Oleanolic acid. |
| OT | Ocotillol. |
| IBD | Inflammatory bowel disease. |
| TNFRs | Tumor necrosis factor receptors. |
| IL-1Rs | Interleukin-1 receptors. |
| RANK | Receptor activator of NF-κB. |
| BAFFR | B cell activating factor receptor. |
| LTβR | Lymphotoxin beta receptor. |
| RANKL | Receptor activator of NF-κB ligand. |
| BAF | B cell activating factor. |
| LTα1β2 | Lymphotoxin alpha/beta. |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor. |
| MAPK | Mitogen-activated protein kinase. |
| JAK | Janus kinase. |
| STAT | Signal transduction and activator of transcription. |
| LPS | Lipopolysaccharide. |
| CNS | Central nervous system. |
| BBB | Blood–brain barrier. |
| ZO-1 | Zonula occludens-1. |
| PPARγ | Proliferator-activated receptor gamma. |
| MMP | Matrix metalloproteinase. |
| CUMS | Chronic unpredictable mild stress. |
| CPZ | Cuprizone. |
| Iba-1 | Ionized calcium-binding adapter molecule-1. |
| CXCL10 | Chemokine ligand 10. |
| 3-NP | 3-nitropropionic acid. |
| HUVECs | Human umbilical vascular endothelial cells. |
| Ang-II | Angiotensin-II. |
| HMGB1 | High mobility group box 1 protein. |
| RAGE | Receptor for advanced glycation end products. |
| ALD | Alcoholic liver disease. |
| NAFLD | Non-alcoholic fatty liver disease. |
| ALT | Alanine transaminase. |
| AST | Aspartate transaminase. |
| LDH | Lactate dehydrogenase. |
| AKP | Alkaline phosphatase. |
| TGF-β1 | Transforming growth factor-beta1. |
| NASH | Nonalcoholic steatohepatitis. |
| FoxO1 | Forkhead box O1. |
| HO-1 | Heme oxygenase-1. |
| Nrf2 | Nuclear factor erythroid-2-related factor 2. |
| ARDS | Acute respiratory syndrome. |
| EMT | Endothelial–mesenchymal transition. |
| LC3 | Microtubule-associated protein light chain 3. |
| Snail | Zinc finger protein SNAI1. |
| Slug | Zinc finger protein SNAI2. |
| TWIST1 | Twist-related protein 1. |
| EGFR | Epidermal growth factor. |
| Akt | Protein kinase B. |
| PD-L1 | Programmed death-ligand 1. |
| PD-1 | Programmed cell death protein 1. |
| IFN-γ | Interferon-gamma. |
| Anxa2 | Annexin A2. |
| PI3K | Phosphatidylinositol 3-kinase. |
| mTOR | Mechanistic target of rapamycin. |